TY - BOOK AU - Welling,Peter G. AU - Lasagna,Louis AU - Banakar,Umesh V. TI - The drug development process SN - 0824797272 (hc : acidfree paper) AV - RM301.25 .D77 1996 U1 - 615.19 20 PY - 1996///] CY - New York PB - M. Dekker KW - Drug development KW - Pharmaceutical industry KW - Drug Evaluation KW - Drug Screening KW - Drug Industry KW - organization & administration KW - Drug Design N1 - Includes bibliographical references and index; Cover; Half Title; Title Page; Copyright Page; Foreword; Preface; Introduction: Whither Drug Development?; Table of Contents; Contributors; Part I: Changing Perspectives in Drug Development; 1. The Evolving Drug Discovery and Development Process; 2. Redefining Competition in the Pharmaceutical Industry: A Time for Choice; Part II: Process Challenges in Drug Development; 3. The Impact of Liability and Cost Containment on the Drug Development Process; 4. Managing the Overall Portfolio for Successful Discovery and Development; Part III: Pharmaceutical and Formulation Factors. 5. Pharmaceutical Issues in Drug Development6. Novel Drug Delivery Systems; Part IV: Drug Design, Pharmacokinetics, and Toxicology; 7. Computer-Aided Drug Design; 8. New Approaches to Nonclinical Biodisposition Studies; 9. Changes in Pharmacokinetics and Drug Metabolism Responsibility in Drug Discovery and Development; Part V: Chemotherapy; 10. Anticancer Drug Development; Part VI: Clinical Studies and the Use of Clinical Research Organizations; 11. Clinical Pharmacology in Drug Development: A View to Future Effectiveness. 12. Contracting CROs into Your Organization: New Strategies for New Challenges13. The Role of Clinical Research Organizations in Drug Development; Part VII: European and Japanese Approaches; 14. Understanding Drug Development and Registration in Japan; 15. Increasing the Effectiveness of Clinical Pathology Testing and Its Value to Drug Development in Europe; 16. New Marketing Authorization Procedures in the European Union and the Impact on Regulatory Strategy; Index N2 - "Containing contributions from the many disciplines involved in a drug's evolution, this timely volume examines the entire pharmaceutical development process, emphasizing approaches to increasing efficiency and reducing costs."--Provided by publisher UR - http://www.loc.gov/catdir/enhancements/fy0647/96024681-d.html ER -